Cue Health develops innovative diagnostic solutions, including portable tests for COVID-19, enhancing healthcare accessibility.

Cue Health (NASDAQ:HLTH) specializes in healthcare technology, focusing on the development of innovative diagnostic solutions for a wide range of medical conditions and diseases. Its offerings aim at empowering individuals and healthcare professionals with accessible, accurate, and rapid testing capabilities. The company's notable projects include the development of portable, point-of-care diagnostic tests for COVID-19, which gained significant attention during the pandemic. Cue Health's objectives are centered around expanding its product lineup, enhancing the integration of its technology with healthcare systems, and making diagnostic testing more convenient and accessible worldwide.